CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
4 research outputs found
Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC).
Author
Brian Lasonde
Carol Aghajanian
+11 more
Christin Whalen
David B. Solit
Eric P. Winer
Gerburg M. Wulf
Gordon B. Mills
Katherine M. Bell-McGuinn
Lewis Cantley
Michael J. Birrer
Philippa Quy
Shannon Neville Westin
Ursula Matulonis
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
A randomized phase 2 trial comparing efficacy of the combination of the PARP inhibitor olaparib and the antiangiogenic cediranib against olaparib alone in recurrent platinum-sensitive ovarian cancer.
Author
Bj Rimel
Christin Whalen
+17 more
Elise C. Kohn
Elizabeth Obermayer
Eric P. Winer
Gini F. Fleming
Hang Lee
Jean Hurteau
Joyce Liu
Jung-min Lee
Mary K. Buss
Michael J. Birrer
Philippa Quy
Ronald J. Buckanovich
S. Percy Ivy
Sreenivasa R. Nattam
Ursula Matulonis
Weixiu Luo
William Thomas Barry
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
A randomized phase 2 trial comparing efficacy of the combination of the PARP inhibitor olaparib and the antiangiogenic cediranib against olaparib alone in recurrent platinum-sensitive ovarian cancer.
Author
Bj Rimel
Christin Whalen
+17 more
Elise C. Kohn
Elizabeth Obermayer
Eric P. Winer
Gini F. Fleming
Hang Lee
Jean Hurteau
Joyce Liu
Jung-min Lee
Mary K. Buss
Michael J. Birrer
Philippa Quy
Ronald J. Buckanovich
S. Percy Ivy
Sreenivasa R. Nattam
Ursula Matulonis
Weixiu Luo
William Thomas Barry
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
Author
Aghajanian
Audeh
+45 more
Bindra
Bindra
BJ Rimel
Bryant
Burger
Cannistra
Christin Whalen
Dean
Elise C Kohn
Eric P Winer
Farmer
Fong
Fong
Gelmon
Gini F Fleming
Hang Lee
Hirte
Jayson
Jean Hurteau
Joyce F Liu
Jung-Min Lee
Kaye
Ledermann
Ledermann
Lim
Lisa Obermayer
Liu
Mary K Buss
Matulonis
Michael Birrer
Moon
Parmar
Pfisterer
Philippa Quy
Pujade-Lauraine
Ronald J Buckanovich
S Percy Ivy
Siegel
Sreenivasa Nattam
Tentori
Tutt
Ursula A Matulonis
Walsh
Weixiu Luo
William T Barry
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref